Showing results (71-80 of 93) with videos related to

Sort By:
Pageof 10
Frontiers in Cell and Developmental Biology|October 31, 2022
A visualization system for erectile vascular dynamicsKota Fujimoto, Daiki Hashimoto, Kenichi Kashimada, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2005
Regulator of complement activation (RCA) locus in chicken: identification of chicken RCA gene cluster and functional RCA proteinsHiroyuki Oshiumi, Kyoko Shida, Ryo Goitsuka, et al.
Medicine|March 31, 2021
Disseminated gonococcal infection in a Japanese man with complement 7 deficiency with compound heterozygous variants: A case reportMisaki Kageyama, Hideharu Hagiya, Yasutaka Ueda, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|April 23, 2011
Multidetector-row computed tomography-based clinical assessment of fondaparinux for treatment of acute pulmonary embolism and acute deep vein thrombosis in Japanese patientsMashio Nakamura, Yoshiaki Okano, Hiroki Minamiguchi, et al.
Vox Sanguinis|November 3, 2023
Comparison of two apheresis systems for granulocyte collection without hydroxyethyl starchHiroki Hosoi, Shiho Nakajima, Hiroshi Tsujimoto, et al.
Clinical and Experimental Nephrology|July 25, 2018
Safety and effectiveness of eculizumab for pediatric patients with atypical hemolytic-uremic syndrome in Japan: interim analysis of post-marketing surveillanceShuichi Ito, Yoshihiko Hidaka, Norimitsu Inoue, et al.
Internal Medicine (Tokyo, Japan)|November 5, 2023
Overlapping Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy with Mutation in CFI in a Japanese Patient: A Case ReportKosuke Osawa, Shuto Yamamoto, Yukiko Yamano, et al.
Clinical and Experimental Nephrology|July 1, 2018
Safety and effectiveness of eculizumab for adult patients with atypical hemolytic-uremic syndrome in Japan: interim analysis of post-marketing surveillanceHideki Kato, Yoshitaka Miyakawa, Yoshihiko Hidaka, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|December 17, 2024
Investigator-initiated, multi-center, single-arm, open-label study of the effectiveness of canakinumab in Japanese patients with Schnitzler syndromeNaotomo Kambe, Mayuko Yamamoto, Koji Takemura, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 28, 2006
Antitumor NK activation induced by the Toll-like receptor 3-TICAM-1 (TRIF) pathway in myeloid dendritic cellsTakashi Akazawa, Takashi Ebihara, Manabu Okuno, et al.
Pageof 10